Product Description: SC209, an ADC cytotoxin extracted from patent WO2021247798, is used in synthesis of anti-EGFR antibody-drug conjugate ADC. SC209 is the payload of STRO-002[1][2].
Applications: Cancer-programmed cell death
Formula: C27H44N4O4
References: [1]Alice Yam, et al. Bispecific antibody-drug conjugates targeting egfr and muc1 and uses thereof. Patent. WO2021247798./[2]De Almeida V, et al. Preclinical activity and safety of STRO-002, a novel ADC targeting folate receptor alpha for ovarian cancer. Gynecologic Oncology, 2018, 149: 50.
CAS Number: 1977557-86-0
Molecular Weight: 488.66
Compound Purity: 99.52
Research Area: Cancer
Solubility: DMSO : ≥ 100 mg/mL
Target: ADC Cytotoxin;Drug Metabolite;EGFR